Passer au titre

Recherche

Translational Medicine and Biomedical Entrepreneurship

DAS

sitem-insel AG

Universität Bern UNIBE

Catégories
Lieu de formation

Berne 10 (BE)

Langue d'enseignement

anglais

Type de formation

Hautes écoles universitaires HEU - Formation continue: formations longues

Modalités temporelles

En emploi

Thèmes de formation

Électronique, microtechnique - Management, direction - Santé, soins, médecine

Filières d'études

Gestion d'entreprise / économie d'entreprise - Médecine humaine - Sciences et technologie biomédicales - Technique médicale

Swissdoc

7.555.33.0 - 7.724.4.0 - 7.616.35.0

Mise à jour 25.09.2024

Description

Description de la formation

Diploma of Advanced Studies (DAS) ist eine Nachdiplomausbildung der Hochschulen und entspricht mindestens 30 ECTS-Punkten.

The program offers continuing education to specialists in industry, hospitals and academia in the field of translational medicine and biomedical entrepreneurship, expertise highly needed in both industry and universities. Participants will acquire
the know-how to initiate and implement the translation process of products from the stage of development in industrial or research institutions to clinical applications with the goal of their commercialization. The focus is on both diagnostic and therapeutic medical devices and medicinal products.

Plan de la formation

The CAS Program consists of 3 out of 5 modules 1-5 plus module 6

  • Module 1: Research and Development (4 ECTS)
    revises basic principles related to the discovery and development of medical devices and medicinal products.
  • Module 2: Good Manufacturing Practice and Quality Management (5 ECTS)
    focusses on how to ensure that all activities linked with a translational process maintain the desired level of excellence required by regulatory agencies.
  • Module 3: Intellectual Property (3 ECTS)
    is dedicated to different types of Intellectual Property and legal aspects that are crucial for the successful commercialization of medical devices and medicinal products.
  • Module 4: Regulatory Affairs (5 ECTS)
    focuses on the approval process for bringing innovative products to the market and describes the role of regulatory agencies, public and government agencies and notified bodies along the translational pathway.
  • Module 5: Clinical Trial Design and Performance (6 ECTS)
    considers key characteristics of clinical trial design and conduct. Participants learn about the prerequisites for such scientific studies, the importance of understanding the pathophysiology of the underlying diseases, the definition of quantifiable endpoints by clinicians as well as data management and statistics.
  • Module 6: Biomedical Entrepreneurship and Management (13 ECTS)
    The development and commer cialization of a new biomedical product involves the coordina tion and leadership of a multidi sciplinary team. The module focuses on various aspects of entrepreneurship such as product management, business administration, and strategies to commercialize biomedical products.

Admission

Conditions d’admission

Participants should have a Master of Science or higher degree in life science, medicine, engineering science or equivalent.

Participants

The program addresses professionals from industry, hospitals and academia that are active in the medical sector and interested in translational medicine and biomedical entrepreneurship.

Coûts

CHF 23'100.-

Diplôme

  • Diploma of Advanced Studies DAS

Diploma of Advanced Studies in Translational Medicine and Biomedical Entrepreneurship, Universität Bern

Infos pratiques

Lieu / adresse

  • Berne 10 (BE)

Déroulement temporel

Début des cours

September

Durée de la formation

4 semesters

Modalités temporelles

  • En emploi

Langue d’enseignement

  • anglais

Remarques

Prerequisites

The prerequisites section is organized as e-learning and offers participants the possibility to refresh their knowledge according to their individual needs, covering the basics of biopharmacy, pharmaceutical technologies, medical technologies, OMICS technologies and biostatistics and epidemiology.

Liens

Renseignements / contact

Prof. Dr. Juergen Burger, Director sitem-insel School, juergen.burger@med.unibe.ch
Dr. Pascale Anderle, deputy Director and program coordinator, pascale.anderle@sitem.unibe.ch
Jennifer.Fischer, administration and communication, jennifer.fischer@sitem.unibe.ch

orientation.ch